首页> 外国专利> Combination of anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases

Combination of anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases

机译:抗CTLA4抗体与依托泊苷的组合用于增生性疾病的协同治疗

摘要

An anti-CTLA-4 and 9- [4,6-O- (R) -ethylidene-β-D-glucopyranoside] antibody of 4'-demethylepipodophyllotoxin, 4 '- (dihydrogen phosphate) or a salt, a solvate or a Pharmaceutically acceptable hydrate thereof, for use in a method for cancer treatment, which comprises administering to a mammal in need thereof a synergistically and therapeutically effective amount of an anti-CTLA-4 antibody with 9- [4,6- O- (R) -ethylidene-β-D-glucopyranoside] of 4'-demethylepipodophyllotoxin, 4 '- (dihydrogen phosphate) or a pharmaceutically acceptable salt, solvate or hydrate thereof.
机译:4'-去甲基表鬼臼毒素,4'-(磷酸二氢盐)或盐,溶剂化物或抗氧化剂的抗CTLA-4和9- [4,6-O-(R)-亚乙基-β-D-吡喃葡萄糖苷]抗体用于药学上可接受的水合物,用于癌症治疗方法,该方法包括对有需要的哺乳动物给予协同和治疗有效量的具有9- [4,6-O-(R)的抗CTLA-4抗体4'-脱甲基表鬼臼毒素,4'-(磷酸二氢)或其药学上可接受的盐,溶剂化物或水合物的[-亚乙基-β-D-吡喃葡萄糖苷]。

著录项

  • 公开/公告号ES2629167T3

    专利类型

  • 公开/公告日2017-08-07

    原文格式PDF

  • 申请/专利权人 BRISTOL-MYERS SQUIBB COMPANY;

    申请/专利号ES20140162613T

  • 发明设计人 LEE FRANCIS;JURE-KUNKEL MARIA;

    申请日2009-10-29

  • 分类号A61K45/06;A61K31/337;A61K31/385;A61K31/506;A61K33/24;A61K39;A61K39/395;C07K16/28;

  • 国家 ES

  • 入库时间 2022-08-21 13:35:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号